Cairn Investment Group, Inc. Gsk PLC Transaction History

Cairn Investment Group, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$42.05 - $47.77 $6,307 - $7,165	-150 Reduced 1.21%	12,250 $533,000
Q1 2022 Apr 26, 2022	SELL	$40.23 - $47.74 $3,017 - $3,580	-75 Reduced 0.6%	12,400 $660,000
Q4 2021 Feb 08, 2022	SELL	$38.88 - $45.31 $75,232 - $87,674	-1,935 Reduced 13.43%	12,475 $550,000
Q3 2021 Nov 09, 2021	SELL	$38.79 - $43.16 $3,103 - $3,452	-80 Reduced 0.55%	14,410 $550,000
Q2 2021 Aug 12, 2021	SELL	$36.52 - $41.46 $98,786 - $112,149	-2,705 Reduced 15.73%	14,490 $576,000
Q1 2021 May 04, 2021	SELL	$34.27 - $40.01 $42,837 - $50,012	-1,250 Reduced 6.78%	17,195 $614,000
Q4 2020 Feb 02, 2021	SELL	$34.07 - $39.94 $32,366 - $37,943	-950 Reduced 4.9%	18,445 $679,000
Q3 2020 Nov 02, 2020	SELL	$38.11 - $42.99 $80,031 - $90,279	-2,100 Reduced 9.77%	19,395 $730,000
Q2 2020 Jul 21, 2020	SELL	$37.87 - $43.58 $19,692 - $22,661	-520 Reduced 2.36%	21,495 $876,000
Q1 2020 Apr 24, 2020	SELL	$32.47 - $48.83 $51,952 - $78,128	-1,600 Reduced 6.78%	22,015 $834,000
Q4 2019 Jan 30, 2020	BUY	$42.0 - $48.25 $991,830 - $1.14 Million	23,615 New	23,615 $1.11 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Cairn Investment Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Cairn Investment Group, Inc. with notifications on news.